CYP1A2 inHibition Examples including Clozapine-Fluvoxamine

Excerpt from Cafer's Mood Stabilizers and Antiepileptics



CYP1A2 inHibition Examples

Ciprofloxacin, a moderate 1A2 inHibitor,  increases clozapine levels about 2-fold.

Fluvoxamine, a strong 1A2 inHibitor, increases clozapine levels 3-fold on average, but up to 10-fold in some cases.           

Kinetic interactions can be more complicated than simply increasing/decreasing concentrations of victim substrates. 

Combining clozapine and fluvoxamine is hazardous, but can potentially be used for therapeutic advantage. Close monitoring of serum clozapine levels would be required.

Norclozapine is the main metabolite of clozapine, formed by 1A2. When clozapine blood levels are reported, clozapine and metabolite (norclozapine) levels are provided separately. Through 1A2 inHibition, Luvox increases the clozapine:norclozapine ratio. A Higher serum clozapine:norclozapine ratio is generally considered desirable*. Norclozapine provides little antipsychotic benefit and causes weight gain, diabetes, seizures, and neutropenia. 

Patients given clozapine 100 mg + Luvox 50 mg daily (compared to clozapine 300 mg monotherapy) demonstrated more improvement with less weight gain. Clozapine levels were similar for both groups with, as expected,  lower norclozapine levels for those taking Luvox. 
(Lu ML et al, 2018; randomized controlled trial, N=85).

*The negative aspect of a Higher clozapine:norclozapine is greater anticholinergic burden (pages 161-162). Clozapine is anticholinergic, whereas norclozapine is cholinergic. Consequently, clozapine causes constipation, while norclozapine does not. The anticholinergic properties of clozapine may impair cognition, whereas norclozapine provides cognitive benefits such as enhanced working memory (page 177).
           

Certain physiologic states may increase levels of olanzapine and clozapine up to 2-fold. 


For a patient with efficacy or tolerability issues, consider monitoring serum levels of the antipsychotic. The author checks clozapine levels routinely, and olanzapine levels in some cases.


Fluvoxamine and ramelteon should not be prescribed concomitantly because ramelteon levels will be increased up to 100-fold!
Copyright 2020, CaferMed LLC









































Comments











Post a Comment























Popular posts from this blog









Cenobamate (XCOPRI) visual mnemonics




















Image







Excerpt from  Cafer's Mood Stabilizers and Antiepileptics, available on Amazon Cenobamate (XCOPRI) “Cinnab on  Ex-co uple ” Pronunciation:  sen oh BAM ate / EX cop ree  ❖ Antiepileptic  ❖ GABA A  modulator  ❖ DEA Schedule V   FDA approved for:   ❖ Partial-onset seizures (adults)   Cenobamate (Xcopri) is the newest antiepileptic drug (AED) , released in 2020. There are some serious risks , side effects and kinetic drug/drug interactions.   Dosing is similar to lamotrigine (Lamictal), with a slow titration to a recommended dose  of 200 mg over 11 weeks . As with lamotrigine, maximum dose is 400 mg. The slow titration is necessary to avoid Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) , also known as multiorgan hypersensitivity. There were no cases of DRESS among over 1,000 patients with adherence to the slow titration schedule. Cenobamate shortens QT  interval and is contraindicated with Familial Short QT Syndrome. QTc interval under 300 is dangerous.   Dose-dependent








Read more










Pregabalin mascot & Black Friday Sale




















Image







Check out the Black Friday sale on Cafer's Psychopharmacology: Visualize to Memorize 270 Medication Mascots.  For a limited time, the paperback is $49.95  and the PDF version is $29.95  (regular price $89.95).  The PDF is formatted for ultra-rapid navigation with thousands of internal links. Included are medication mascots to assist you with memorization of trade name / generic name pairings. Here are excerpts from from 5-star Amazon reviews: ★★★★★ Love it I barely look at the pictures, honestly. I'm most impressed by the way the author explains everything through text, simply and efficiently. ★★★★★  GREAT PSYCH NO STUDENT EASY TO READ RESOURCE This breaks things down easily and is a great study resource for those needing something more concise and easier to read. ★★★★★  THIS BOOK helped me SO MUCH! First of all, I don’t write reviews but this book deserves it. I am in a CMHC graduate program where a class asked me to know most of the antipsychotics and antidepressants. It was 








Read more










Lumateperone (Caplyta)




















Image







Available on Amazon:  Cafer's Mood Stabilizers and Antiepileptic Drugs        Lumateperone (CAPLYTA) Pronunciation:  luma TEP er ohn / cap LIE ta  “’Lum inated  Cap lighter” Antipsychotics are represented  with spooky mascots. Year of US release: 2020  ❖ Antipsychotic (SGA) ❖ D2 antagonist - ⇩DA ❖ 5-HT2A antagonist - ⇧DA ❖ Glutamate modulator  FDA-approved for:  ❖ Schizophrenia  Lumateperone is a new antipsychotic that purportedly modulates glutamate  in addition to the usual SGA mechanism of blocking D2 and 5-HT2A receptors. However, the official prescribing information does not mention glutamate, suggesting the FDA saw insufficient evidence for lumateperone being a first-in-class novel antipsychotic. It appears to be equally effective as risperidone (Risperdal) with fewer side effects other than sedation (Citrome, 2016).  Lumateperone’s D2 receptor occupancy is lower than most other antipsychotics. This means extrapyramidal side effects are unlikely. The other antipsychotics with








Read more